31-10-2011 17:20 A lecture by Kevin Ahern of Oregon State University to his BB 450/550 class. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 451 - oregonstate.edu BB 100 - oregonstate.edu Topics covered include protein kinase A, allosterism, regulation, kinases, phosphatases, serines, threonines, tyrosines, covalent modification, protease, pancreatitis, peptide bond, zymogen, elastase, anti-trypsin, trypsin inhibitor, elastase inhibitor, lungs, smoking, oxidation, emphysema, and blood clotting.

Continue reading here:
#15 Biochemistry Enzyme Regulation II Lecture for BB 450/550 Fall 2011 - Video

17-10-2011 06:08 Is Evolution a Reasonable Scientific Theory? Dr. James Paulson, professor of biochemistry at the University of Wisconsin, Oshkosh, tries to defend evolution as a valid scientific theory to the room crammed with university students. April 2000. Antigua Barbuda Australia Bahamas Barbados Beliza Botswana Britain Brunei Cameroon Canada Dominica England Ethiopia Fiji Gambia Germany Ghana Great Britain Grenada Guyana India Ireland Israel Jamaica Kenya Kiribati Lesotho Liberia Malawi Malta Marshall Islands Mauritius Micronesia Namibia Nauru New Zealand Nigeria Pakistan Palau Papua New Guinea Philippines Pilipinas Rwanda Saint Kitts Saint Nevis Saint Lucia Saint Vincent Grenadines Samoa Scotland Seychelles Sierra Leone Singapore Solomon Islands South Africa Swaziland Tanzania Tonga Trinidad and Tobago Tuvalu Uganda UK United Kingdom United States USA Vanuatu Zambia Zimbabwe English

Continue reading here:
Kent Hovind - Debate 10 - Dr. Hovind vs. Professor of Biochemistry Dr. James Paulson - Video

23-11-2011 11:29 Muscle calcium and the biochemistry of actin -myosin crosslinking for contraction by striated muscle of invertebrate animals.

Originally posted here:
5. Calcium and the Biochemistry of Muscle Contraction (Invertebrate) - Video

14-11-2011 16:27 A lecture by Kevin Ahern of Oregon State University to his BB 450/550 class. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 451 - oregonstate.edu BB 100 - oregonstate.edu Topics covered include enzyme categories, EC numbers, glycolysis, glucose metabolism, glucose, glucose-6-phosphate, G6P, F6P, F1,6BP, fructose, fructose-6-phosphate, hexokinase, PFK, phosphofructokinase, aldolase, DHAP, G3P, oxidation, NAD, NADH, trios phosphate isomerase, ATP, energy, metabolic, 2,3BPG, substrate level phosphorylation

Originally posted here:
#21 Biochemistry Glycolysis Lecture for BB 450/550 Fall 2011 - Video

07-11-2011 17:39 A lecture by Kevin Ahern of Oregon State University to his BB 450/550 class. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 451 - oregonstate.edu BB 100 - oregonstate.edu Ahern of Oregon State University to his BB 450/550 class. Topics covered include flu tamiflu, neuraminidase, hemagglutanin, beta adrenergic receptor, epinephrine, flight or fright, adrenal glands, 7TM, transmembrane, G-protein, GDP, GTP, adenylate cyclase, cAMP, protein kinase A, phospholipase C, angiotensin, blood pressure, second messenger, hormone, first messenger, insulin, calcium, IP3, DAG, PIP2, glucose, poison, and protein kinase C.

Originally posted here:
#18 Biochemistry Signaling I Lecture for BB 450/550 Fall 2011 - Video

03-02-2012 16:32 A lecture by Kevin Ahern of Oregon State University to his BB 451/551 class. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 450 - oregonstate.edu BB 100 - oregonstate.edu Topics include LDLs, VLDLs, HDLs, IDLs, chylomicrons, regulation, metabolism, atherosclerosis, SREBP, HMG-CoA reductase, lovastatin, statins, cholesterol levels, cholesterol, familial hypercholesterolemia, endocytosis, LDL receptor, lipoprotein complexes, bile salt, bile acid, steroid hormone, hormone, testosterone, estradiol, androgens, estrogens, vitamin D, cholecalciferol, fatty acids, oxidation, fat, lipid, metabolism

Go here to read the rest:
#36 Biochemistry Cholesterol in the Body Lecture for BB 451/551 Winter 2012 - Video

27-01-2012 16:28 A narrated tour of UW-Madison's Biochemistry Complex led by biochemistry professor Mike Cox. For more information about the biochemistry department, visit: http://www.biochem.wisc.edu For more news from the UW-Madison College of Agricultural and Life Sciences, visit: news.cals.wisc.edu

Excerpt from:
UW-Madison's Biochemistry Complex - Video

06-02-2012 17:15 A lecture by Kevin Ahern of Oregon State University to his BB 451/551 class. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 450 - oregonstate.edu BB 100 - oregonstate.edu Topics include fat, fats, fatty acids, glycerol, metabolism, oxidation, regulation, receptor, adrenergic receptor, palmitate, palmitic acid, succinate, saturated fatty acid, unsaturated fatty acid, dehydrogenation, hydration, oxidation, thiolytic cleavage, thiolase, ketone bodies, SIDS, human health, acyl-CoA dehydrogenase, peroxisome, B12, propionyl-CoA, malonyl-CoA, synthesis, acetyl-CoA carboxylase, unsaturated fatty acid oxidation, ketone bodies, ketone body, brain, diabetes, acetone, acetoacetyl-CoA, beta hydroxybutyrate, hypoglycemia.

See more here:
#37 Biochemistry Fat/Fatty Acid Metabolism I Lecture for BB 451/551 Winter 2012 - Video

More Photos

Click thumbnails to enlarge

Telly (rear) is played by Angelo Williams.

Angelo Williams as Telly Monster, appearing in "Sesame Street Live: Elmo’s Super Heroes" at the Fisher Theatre.

By BETH ROBINSON
For Journal Register Newspapers

Former Detroiter Angelo Williams is touring with the company of "Elmo's Super Heroes" as Telly Monster.

Former Detroiter Angelo Williams has a degree in biochemistry; maybe as many stamps in his passport as Hillary Clinton; and a fuzzy purple alter ego.

Williams, 28, who graduated from Detroit’s High School of Arts, plays Telly Monster, one of the eponymous superheroes of “Sesame Street Live – Elmo’s Super Heroes.”

An “Army brat” born in Nuremberg, Germany, Williams was already well travelled before hitting Motown, Main Street and, finally, touring with Sesame Street. After graduating from high school, Williams did a year at Wayne State University before heading south to dance at Disney World in shows such as the Magic Kingdom’s Main Street Trolley Show and The Festival of the Lion King at Disney’s Animal Kingdom.

He credits a lot of water and Gatorade with his survival. “It’s a lot of hard work, especially in the summer when it’s 98 degrees when you’re in a button-up shirt and vest,” Williams said.

While in Orlando, Fla., he had a visit from a friend and fellow dancer from the Freedom Dance Expressions Company, who was touring with "Dragon Tales Live." Like "Sesame Street Live," it was produced by the VEE Corp. He spent time with the "Dragon Tales" company while they were performing in Orlando, and was invited to audition.

He began his first tour with "Sesame Street Live" in 2005, as Big Bird in “Super Grover Ready for Action,” the original version of the recently updated “Elmo’s Super Heroes.”

Williams has toured with each of the three touring casts of "Sesame Street Live" for the last seven years, playing both Big Bird and Telly, who was Williams’ favorite as a kid.

“He’s very quirky and he’s very spastic, too. He can be very upbeat and then be down a little,” said Williams.

The three casts tour the East Coast, the West Coast and the theater circuit with different shows, and each has international stops. Williams said his most interesting stop was Singapore. The company spent New Year’s Eve in Mexico City, where the soundtrack for the show is in Spanish.

He says that Sesame Street is every bit as beloved around the world as it is here at home. Continued...

“The show offers so much for all ages,” said Williams, whose favorite song in the current show is a take on “One” from “A Chorus Line.” “It’s like we’re in a Broadway show.”

Between tours, Williams earned a dual degree in dance education and biochemistry from the University of Central Florida. His residence is in Newark, Del.

He likes to read, and do gymnastics and has participated on competition cheer teams. The last book he read was the final Harry Potter book, which he saved for after seeing the movie, because he didn’t want to be disappointed. This way, Williams’ reasons, “The book just totally fills in the blanks.”

Asked if he’s interested in the movie business, Williams laughed. "Not unless I hit the lottery.”

Williams has a 6-year-old nephew and a niece on the way. His nephew has seen “every show I’ve been in since he was born. I’m the cool uncle.”

The next move for the multitalented Williams “is to figure out a longterm goal.” He says he is “getting ready for family mode” now, and would like to either open a dance studio and teach or put his biochemistry degree to work in research, where he’s leaning toward pharmaceuticals.

But his most immediate plan is to hustle off to Buffalo for another opening and another show of "Sesame Street Live."

See the rest here:
Multitalented Detroiter loves being Telly Monster in ' Sesame Street Live'

03-08-2011 12:33 (01/05/11) Lecture by Kevin Ahern of Oregon State University discussing Biochemistry Basics in BB 451. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 450 - oregonstate.edu BB 100 - oregonstate.edu Lecture Summary Citric Acid II 1. The first decarboxylation of the citric acid cycle is catalyzed by isocitrate dehydrogenase and the reaction is strongly favored to the right. The products of this reaction are NADH and alpha ketoglutarate. 2. Alpha ketoglutarate is an important intermediate for its involvement in anaplerotic reactions related to transamination (we'll talk about these later). The products of this reaction are succinyl-CoA and NADH 3. The only substrate level phosphorylation in the citric acid cycle is catalyzed by succinyl-CoA synthetase. The products of this reaction in the citric acid cycle are GTP and succinate. 4. Succinate dehydrogenase contains a covalently-linked FAD electron carrier. The Delta G zero prime of zero allows the reaction to be readily reversed to produce succinate, when needed. The products of this reaction in the forward direction of the citric acid cycle are FADH2 and fumarate (trans double bond). 5. Addition of water to fumarate (catalyzed by fumarase) yields L-malate. 6. Oxidation of L-malate by malate dehydrogenase yields NADH ...

Read this article:
Bite-Sized Biochemistry #28 - Citric Acid Cycle II (Oxidative Metabolism) - Video

NEW YORK, Feb. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Strategic Analysis of the European Stem Cell Research Tools Market

http://www.reportlinker.com/p0769016/Strategic-Analysis-of-the-European-Stem-Cell-Research-Tools-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy

The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research: bio-imaging and microscopy, cell biology tools, immunochemicals, molecular biology tools, and protein biochemistry tools. The study also looks into the usage pattern of these tools. An extensive end-user survey was conducted with 25 laboratories to assess the requirement and usage of tools. Insightful review of key industry drivers, restraints and challenges have been discussed. Leading market players and the prevailing competitive landscape for each of the segments have been discussed.

Table of ContentsExecutive Summary 10-19

Executive Summary 11-13

Market Engineering Measurements 14

Scope & Objective 15

Technologies Employed for Stem Cell Research 16

Stem Cell Research Protocol 17

CEO's Perspective 18

Exchange Rates 19

Market Overview 19

Market Overview - Definitions 20-24

Market Overview 25-26

Market Overview - Segmentation 27

European Stem Cell Research End User Trends 28

Stem Cell Research Workflow 29

Purpose of Research and Profile of Respondents 30

Stem Cells and Tools Usage Trends 31-33

Tools and Equipment Budget for Stem cell research Tools 34

Market Outlook 35

Market Age 36

Funding for Stem Cell Program 37-39

External Challenges: Drivers and Restraints 40

Industry Challenges 41-45

Drivers & Restraints 46

Key Market Participants 52

Product Line Analysis 59

Forecasts and Trends -Total Stem Cell Research Tools Market 70

Forecast Assumptions 72

Revenue Forecasts 73-74

Bio Imaging Tools In Vivo and In Vitro Segment Breakdown 75

Revenue Forecasts 77-78

Market Share Analysis 79

Cell Biology, Protein Biochemistry, and Immunochemical Tools Segment Breakdown 80

Revenue Forecasts 82-83

Market Share Analysis 84

Molecular Biology Tools Segment Breakdown 85

Revenue Forecasts 87-88

Market Share Analysis 89

Demand Analysis 90

Bioimaging Tools In Vivo and In Vitro 92

Cell Biology Tools 93

Demand Analysis Molecular Biology Tools 94

Protein Biochemistry Tools 95

Immunochemical Tools 96

European Stem Cell Research Centers 97-99

SWOT Analysis 101-102

Strategic Recommendations and Conclusions 103-106

The Last Word 107

Appendix 110

List of Figures

Total Stem Cell Research Tools Market: Market Overview, Europe, 2010 25Total Stem Cell Research Tools Market: Tools Usage Trends, Europe, 2010 32-33Total Stem Cell Research Tools Market: Market Outlook, Europe, 2010 35Total Stem Cell Research Tools Market: R&D Programs Funded, Europe, 2006–2013 37Total Stem Cell Research Tools Market: Bioimaging Tools In Vivo and In Vitro End User Analysis, Europe, 2010 92Total Stem Cell Research Tools Market: Cell Biology Tools End User Analysis, Europe, 2010 93Total Stem Cell Research Tools Market: Molecular Biology Tools End User Analysis, Europe, 2010 94Total Stem Cell Research Tools Market: Protein Biochemistry Tools End User Analysis, Europe, 2010 95Total Stem Cell Research Tools Market: Immunochemical Tools End User Analysis, Europe, 2010 96

List of Charts

Percent Revenue Breakdown Total Stem Cell Research Tools Market: Europe, 2010 27

Percent Revenue Breakdown Total Stem Cell Research Tools Market: Europe, 2017 27

Total Stem Cell Research Tools Market: Purpose of Research and Profile of Respondents, Europe, 2010 30

Total Stem Cell Research Tools Market: General and Primary Focus on Stem Cell Research, Europe, 2010 31

Total Stem Cell Research Tools Market: Lab Budgets, Europe, 2010 34

Total Stem Cell Research Tools Market: Lab Budget Estimations, Europe, 2011 34

Total Stem Cell Research Tools Market: Segment Life Cycle Analysis, Europe, 2010 36

Total Stem Cell Research Tools Market: Industry Challenges, Europe, 2011–2017 41

Total Stem Cell Research Tools Market: Drivers and Restraints, Europe, 2010 46

Total Stem Cell Research Tools Market: Product Line Analysis, Europe, 2010 59-67

Market Overview Total Stem Cell Research Tools: Europe, 2010 71

Total Stem Cell Research Tools: Revenue Forecast, Europe, 2010–2017 73

Market Overview Bioimaging In Vivo and In Vitro Market: Europe, 2010 76

Bioimaging Tools In Vivo and In Vitro Market: Revenue Forecasts, Europe, 2010–2017 77

Bioimaging In Vivo and In Vitro Market: Market Share Analysis, Europe, 2010 79

Market Overview Cell Biology, Protein Biochemistry, and Immunochemical Tools Market: Europe, 2010 81

Cell biology, Protein Biochemistry, and Immunochemical Tools Market Revenue Forecasts, Europe, 2010–2017 82

Cell Biology, Protein Biochemistry, and Molecular Biology Tools Market: Market Share Analysis, Europe, 2010 84

Market Overview Molecular Biology Tools Market: Europe, 2010 86

Molecular Biology Tools Market: Revenue Forecasts, Europe, 2010–2017 87

Molecular Biology Tools Market: Market Share Analysis, Europe, 2010 89

Total Stem Cell Research Tools Market: Research Centers and Universities, Europe, 2010 98-100

Total Stem Cell Research Tools Market: SWOT Analysis, Europe, 2010 102

To order this report:Biological Therapy Industry: Strategic Analysis of the European Stem Cell Research Tools Market

More  

Market Research Report

Check our  

Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

See more here:
Strategic Analysis of the European Stem Cell Research Tools Market

WINDSOR, ONTARIO--(Marketwire - Feb. 3, 2012) - Essex Angel Capital Inc. (TSX VENTURE:EXC.V - News) (the "Corporation" or "Essex") is pleased to announce that Denis Callewaert, Founder and Chief Science Officer of Wellness Indicators, Inc. ("Wellness Indicators"), one of the companies in the Essex portfolio, will be a guest speaker at the National Labor Management Conference in Hollywood, FL, February 16-21, 2012. Dr. Callewaert, who holds a Ph.D. in biochemistry, will be addressing the attendees about the unique aspects of Wellness Indicators' new wellness screening test, the Health Equater(TM) Assessment Profile.

One thousand attendees at the National Labor Management Conference will be offered the opportunity to participate in field trials of the Health Equater Assessment Profile, which is a quick and inexpensive urine test that screens for biomarkers indicating levels of wellness. The National Labor Management Conference is only one of the sites where the Health Equater Assessment Profile will be field-tested. Further field trials during the first quarter of 2012 will take place at a number of large insurance companies, large employers and organized labor unions. Wellness Indicators has field trial commitment letters from eight organizations, representing over 1,000,000 potential users, of whom 2,000 will be participating in field trials in the first quarter of 2012.

"Wellness Indicators is a game-changer in the Labor space," said Ed Hanley, former Chief Legal Counsel of Hotel Employees and Restaurant Employees and Bartenders International Union and current CEO of A&E Group Health Solutions LLC, "which brings a non-invasive, portable, affordable method for funds and their members to manage their own personal health. I am excited to share this new solution next week at the National Labor Conference, where some 1,000 different funds will be represented."

An international expert in biochemistry and immunology, with a focus on biomarkers for oxidative stress and inflammation, Dr. Callewaert has founded four biotechnology companies, including Wellness Indicators. The company plans to introduce the Health Equater Assessment Profile commercially, after field tests are completed.

The Health Equater Assessment Profile is a first-to-market test screening for such biomarkers as oxidative stress, low-grade inflammation and total antioxidant capacity, which indicate levels of wellness. Thousands of studies have shown that the biomarkers detected by the assessment profile are leading indicators for a variety of future health risks, including stroke, cancer, heart disease, and diabetes. The value of the Health Equater Assessment Profile is that it is non-invasive, results are ready in five minutes and it gives an indication at the individual level of how a person is functioning metabolically before the onset of chronic disease, when intervention is less expensive and more effective. Results are available in approximately five minutes, instead of the week that traditional lab tests require. Other advantages include ease of use, portability, and low cost, being approximately $30 per test, rather than around $100 for most current diagnostic tests.

"The field trials at the National Labor Management Conference, is a significant step forward for Wellness Indicators," said Rick Galdi, President and CEO of Essex. "The invitation for Dr. Callewaert to speak on the subject and the immediate availability to participate in the trial lays a strong foundation for future test sales."

This press release contains certain forward-looking statements about the future plans and intentions of companies in the Corporation's portfolio. Wherever possible, words such as "may," "will," "should," "could," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," or "potential," or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect Management's current beliefs and are based on information currently available to Management as at the date hereof. Forward-looking statements included or incorporated by reference in this press release include statements with respect to completion of Wellness Indicators' field trials in the first quarter of 2012, successful commercial launch of the Health Equator Assessment Profile later this year and the future business activity of Wellness Indicators.

Forward-looking statements involve significant risk, uncertainties, and assumptions. Many factors could cause actual results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, the Corporation cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and the Corporation assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Read more:
Essex Angel Capital Inc. Announces: Wellness Indicators, Inc. Founder Is Guest Speaker at National Labor Management ...

Public release date: 1-Feb-2012
[ | E-mail | Share ]

Contact: Susan Chaityn Lebovits
lebovits@brandies.edu
781-726-4027
Brandeis University

Bacterial resistance to antibiotics is growing exponentially, contributing to an estimated 99,000 deaths from hospital-associated infections in the U.S. annually, according to the Centers for Disease Control and Prevention. One reason that this is happening is that drug resistant proteins are transporting "good" antibiotics, or inhibitors, out of the cells, leaving them to mutate.

In a paper recently published in the journal Nature, Professor of Biochemistry Dorothee Kern and collaborators including former postdoctoral student Katherine A. Henzler-Wildman, looked at how one of these drug transporters, EmrE, works. The hope is that someday a drug will be developed to impede this motion of transport.

"You have a disease and an antibiotic goes into the cells to try to kill it," explains Kern. "But the protein EmrE takes the antibiotic and transports it out. The goal would be to find clever ways to stop EmrE from functioning as an exporter while allowing necessary nutrients to remain"

The challenge with making drugs, says Kern, is that you need to kill specific targets but nothing else.

Kern and her team studied the protein using nuclear magnetic resonance (NMR) spectroscopy, adding a drug mimetic in order to learn how the structure EmrE was designed and how it functioned as it was transporting ? moving the drug from inside of the cell to the outside. Currently there are around 12 to 13 similarly known proteins within the EmrE family.

Increasing the knowledge of how this protein works will hopefully help to target all of them. Once you understand that, you could design inhibitors that do not allow the protein to transport the "good" drugs out.

"We were actually looking at a transporter in real time," says Kern. "That is something very novel as previously these structures were only seen by X-ray crystallography, so they were frozen, and not moving."

Kern says EmrE actually bounces back and forth between two alternate conformations, hand-shaped structures that take one molecule, pump it out, return to grab the next one, then pumps that one out (Fig. 1).

"The cool thing about discovering how the protein functions is that this was unexpected," says Kern. "Everyone thought that the inside and the outside had two different structures."

Kern says that she is extremely proud of her former postdoctoral student, who began working on the project at Brandeis in 2006 and has continued pushing and leading this project at Washington University in St. Louis, where she is now an assistant professor of ?biochemistry and molecular biophysics.

"Before Katie had worked out the kinks, my lab continued to make proteins for her and shipped them there," says Kern. "In collaboration with postdoctoral fellow Michael Clarkson, the NMR dynamics experiments were collected at Brandeis. It's been a real fun collaboration."

Why are there so many resistant strains of bacteria?

Antibiotics try to kill bacteria. To avoid being killed bacteria mutate, meaning that they change the structure of the amino acids within their cell. This way the protein is no longer able to be taken over by the antibiotic.

"These bacteria survive and duplicate every 20 minutes," says Kern. "Now you have a new strain, a new form of bacteria and the designed drug no longer works. This survival and changing of composition occurs when an antibiotic encounters them."

As more antibiotics are being used, more new strains of bacteria are created that are resistant to current antibiotics, which is why bacteria and viruses are harder to target.

"It's called mutagenesis?changes in the genomic material and bacteria can do this very quickly," says Kern. "If you look at the statistics, the numbers of resistant strains are exponentially growing."

Kern cautions against purchasing anti-bacterial products such as cutting boards, soaps and toothpaste as they are contributing to this rash of mutations.

"If you have an infection and use a high concentration of antibiotics, the bacteria are being killed before they can adapt and change,"says Kern. "If the dose is very small, they are not all getting killed, and they have time to mutate."

Kern says this is another reason why it is so crucial to complete a prescribed course of antibiotics when you're sick even if you're asymptomatic ?if 95 percent of the bacteria are gone, there is still five percent that can develop resistance in a matter of days.

###

[ | E-mail | Share ]

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

See original here:
A step closer to understanding, averting drug resistance

03-08-2011 12:48 (01/12/11) Lecture by Kevin Ahern of Oregon State University discussing Biochemistry Basics in BB 451. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus.

Read more here:
Bite-Sized Biochemistry #31 - Membrane Transport II - Video

03-08-2011 14:37 (03/04/11) Lecture by Kevin Ahern of Oregon State University discussing Biochemistry Basics in BB 451. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 450 - oregonstate.edu BB 100 - oregonstate.edu Highlights Gene Expression 2 1

Read more from the original source:
Bite-Sized Biochemistry #50 - Gene Expression II - Video

03-08-2011 13:42 Lecture by Kevin Ahern of Oregon State University discussing Biochemistry Basics in BB 451. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus.

Read the original here:
Bite-Sized Biochemistry #41 - DNA Replication, Repair, Recombination I - Video

01-10-2011 17:35 Alecture by Kevin Ahern to BB 450/550 at Oregon State University.

The rest is here:
#03 Biochemistry Amino Acids Lecture for BB 450/550 Fall 2011 - Video

03-08-2011 12:28 (01/03/11) Lecture by Kevin Ahern of Oregon State University discussing Biochemistry Basics in BB 451. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus

Read this article:
Bite-Sized Biochemistry #27 - Citric Acid Cycle I (Oxidative Metabolism) - Video

Lecture by Kevin Ahern of Oregon State University discussing Protein Structure II in BB 450. This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu See the full course at oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 451 - oregonstate.edu BB 100 - oregonstate.edu Highlights Protein Structure 3 1

Read the original here:
Bite-Sized Biochemistry #5: Protein Structure III - Video

Lecture by Kevin Ahern of Oregon State University discussing Protein Structure II in BB 450. This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu See the full course at oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 451 - oregonstate.edu BB 100 - oregonstate.edu Highlights Protein Structure IV 1.

See the original post:
Bite-Sized Biochemistry #6: Protein Structure